The Journal of General Physiology
89 NORTH - Illumination Systems for Fluorescence Imaging
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 1 September 2001. doi:10.1085/jgp.118.3.277
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 206K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JGP
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avila, G.
Right arrow Articles by Dirksen, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avila, G.
Right arrow Articles by Dirksen, R. T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1295/2001//277/ $5.00
Journal of General Physiology, Volume 118, Number 3, 2001

Original Article

Functional Effects of Central Core Disease Mutations in the Cytoplasmic Region of the Skeletal Muscle Ryanodine Receptor

Guillermo Avilaa and Robert T. Dirksena

a Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642
Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642.(716) 273-2652

robert_dirksen{at}URMC.rochester.edu

Central core disease (CCD) is a human myopathy that involves a dysregulation in muscle Ca2+ homeostasis caused by mutations in the gene encoding the skeletal muscle ryanodine receptor (RyR1), the protein that comprises the calcium release channel of the SR. Although genetic studies have clearly demonstrated linkage between mutations in RyR1 and CCD, the impact of these mutations on release channel function and excitation-contraction coupling in skeletal muscle is unknown. Toward this goal, we have engineered the different CCD mutations found in the NH2-terminal region of RyR1 into a rabbit RyR1 cDNA (R164C, I404M, Y523S, R2163H, and R2435H) and characterized the functional effects of these mutations after expression in myotubes derived from RyR1-knockout (dyspedic) mice. Resting Ca2+ levels were elevated in dyspedic myotubes expressing four of these mutants (Y523S > R2163H > R2435H R164C > I404M RyR1). A similar rank order was also found for the degree of SR Ca2+ depletion assessed using maximal concentrations of caffeine (10 mM) or cyclopiazonic acid (CPA, 30 µM). Although all of the CCD mutants fully restored L-current density, voltage-gated SR Ca2+ release was smaller and activated at more negative potentials for myotubes expressing the NH2-terminal CCD mutations. The shift in the voltage dependence of SR Ca2+ release correlated strongly with changes in resting Ca2+, SR Ca2+ store depletion, and peak voltage–gated release, indicating that increased release channel activity at negative membrane potentials promotes SR Ca2+ leak. Coexpression of wild-type and Y523S RyR1 proteins in dyspedic myotubes resulted in release channels that exhibited an intermediate degree of SR Ca2+ leak. These results demonstrate that the NH2-terminal CCD mutants enhance release channel sensitivity to activation by voltage in a manner that leads to increased SR Ca2+ leak, store depletion, and a reduction in voltage-gated Ca2+ release. Two fundamentally distinct cellular mechanisms (leaky channels and EC uncoupling) are proposed to explain how altered release channel function caused by different mutations in RyR1 could result in muscle weakness in CCD.

Key Words: excitation-contraction coupling • calcium channels • muscle disease • calcium homeostasis

© 2001 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Boncompagni, A. E. Rossi, M. Micaroni, S. L. Hamilton, R. T. Dirksen, C. Franzini-Armstrong, and F. Protasi
Characterization and temporal development of cores in a mouse model of malignant hyperthermia
PNAS, December 22, 2009; 106(51): 21996 - 22001.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
W. Klingler, H. Rueffert, F. Lehmann-Horn, T. Girard, and P. M. Hopkins
Core Myopathies and Risk of Malignant Hyperthermia
Anesth. Analg., October 1, 2009; 109(4): 1167 - 1173.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. Dainese, M. Quarta, A. D. Lyfenko, C. Paolini, M. Canato, C. Reggiani, R. T. Dirksen, and F. Protasi
Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice
FASEB J, June 1, 2009; 23(6): 1710 - 1720.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Andronache, S. L. Hamilton, R. T. Dirksen, and W. Melzer
A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice
PNAS, March 17, 2009; 106(11): 4531 - 4536.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. D. Lyfenko and R. T. Dirksen
Differential dependence of store-operated and excitation-coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1
J. Physiol., October 15, 2008; 586(20): 4815 - 4824.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Zvaritch, F. Depreux, N. Kraeva, R. E. Loy, S. A. Goonasekera, S. Boncompagni, A. Kraev, A. O. Gramolini, R. T. Dirksen, C. Franzini-Armstrong, et al.
An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line
PNAS, November 20, 2007; 104(47): 18537 - 18542.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
T. Yang, E. Esteve, I. N. Pessah, T. F. Molinski, P. D. Allen, and J. R. Lopez
Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1591 - C1598.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
D. Rossi, P. De Smet, A. Lyfenko, L. Galli, S. Lorenzini, D. Franci, F. Petrioli, A. Orrico, C. Angelini, V. Tegazzin, et al.
A truncation in the RYR1 gene associated with central core lesions in skeletal muscle fibres
J. Med. Genet., February 1, 2007; 44(2): e67 - e67.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Wu, M C. A. Ibarra, M. C. V. Malicdan, K. Murayama, Y. Ichihara, H. Kikuchi, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino
Central core disease is due to RYR1 mutations in more than 90% of patients
Brain, June 1, 2006; 129(6): 1470 - 1480.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Brini, S. Manni, N. Pierobon, G. G. Du, P. Sharma, D. H. MacLennan, and E. Carafoli
Ca2+ Signaling in HEK-293 and Skeletal Muscle Cells Expressing Recombinant Ryanodine Receptors Harboring Malignant Hyperthermia and Central Core Disease Mutations
J. Biol. Chem., April 15, 2005; 280(15): 15380 - 15389.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. G. Weiss, K. M. S. O'Connell, B. E. Flucher, P. D. Allen, M. Grabner, and R. T. Dirksen
Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling
Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1094 - C1102.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. D. Fessenden, C. F. Perez, S. Goth, I. N. Pessah, and P. D. Allen
Identification of a Key Determinant of Ryanodine Receptor Type 1 Required for Activation by 4-Chloro-m-cresol
J. Biol. Chem., August 1, 2003; 278(31): 28727 - 28735.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Avila, E. H. Lee, C. F. Perez, P. D. Allen, and R. T. Dirksen
FKBP12 Binding to RyR1 Modulates Excitation-Contraction Coupling in Mouse Skeletal Myotubes
J. Biol. Chem., June 13, 2003; 278(25): 22600 - 22608.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
N. Monnier, A. Ferreiro, I. Marty, A. Labarre-Vila, P. Mezin, and J. Lunardi
A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia
Hum. Mol. Genet., May 15, 2003; 12(10): 1171 - 1178.
[Abstract] [Full Text] [PDF]

Home page
 JGPHome page
G. Avila, K. M. S. O'Connell, and R. T. Dirksen
The Pore Region of the Skeletal Muscle Ryanodine Receptor Is a Primary Locus for Excitation-Contraction Uncoupling in Central Core Disease
J. Gen. Physiol., March 31, 2003; 121(4): 277 - 286.
[Abstract] [Full Text] [PDF]

Home page
 JGPHome page
K. M.S. O'Connell, N. Yamaguchi, G. Meissner, and R. T. Dirksen
Calmodulin Binding to the 3614-3643 Region of RyR1 Is Not Essential for Excitation-Contraction Coupling in Skeletal Myotubes
J. Gen. Physiol., August 26, 2002; 120(3): 337 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
D. Jiang, B. Xiao, L. Zhang, and S.R. W. Chen
Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (Ryanodine Receptor) Mutant Associated With Ventricular Tachycardia and Sudden Death
Circ. Res., August 9, 2002; 91(3): 218 - 225.
[Abstract] [Full Text] [PDF]


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents